Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$106

Avg closing price
Price range

2 David Abrams Horizon Therapeutics Plc Trades

David Abrams started to build up the position in Horizon Therapeutics Plc in Q2 2023. Since then they sold 891 Thousand shares. The investor sold all their shares in Q3 2023 and doesn't own any shares in Horizon Therapeutics Plc anymore.

Avg closing price
Price range
Sold -891 Thousand shares Q3 2023
Avg closing price $107.45
Price range $98.98 - $115.74
New holding (+891 Thousand shares) Q2 2023
Avg closing price $105.50
Price range $96.34 - $112.38

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!